256 related articles for article (PubMed ID: 23510764)
1. Human papillomavirus (HPV) and related cancers in the Global Alliance for Vaccines and Immunization (GAVI) countries. A WHO/ICO HPV Information Centre Report.
de Sanjosé S; Serrano B; Castellsagué X; Brotons M; Muñoz J; Bruni L; Bosch FX
Vaccine; 2012 Nov; 30 Suppl 4():D1-83, vi. PubMed ID: 23510764
[No Abstract] [Full Text] [Related]
2. The announcement by the GAVI Alliance Board to support human papillomavirus (HPV) vaccines in the world's poorest countries.
Vaccine; 2012 Nov; 30 Suppl 4():xii. PubMed ID: 23510773
[No Abstract] [Full Text] [Related]
3. Mathematical models of cervical cancer prevention in the Asia Pacific region.
Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
[TBL] [Abstract][Full Text] [Related]
4. The Global Alliance for Vaccines and Immunization (GAVI).
Schwalbe N
Vaccine; 2012 Nov; 30 Suppl 4():x. PubMed ID: 23510771
[No Abstract] [Full Text] [Related]
5. HPV-related cancer prevention through coalition building.
Lind E; Welch K; Perkins RB
Hum Vaccin Immunother; 2017 Oct; 13(10):2300-2306. PubMed ID: 28901813
[No Abstract] [Full Text] [Related]
6. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
Khaliq SA; Shyum Naqvi SB; Fatima A
Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus, vaccines and women's health: questions and cautions.
Lippman A; Melnychuk R; Shimmin C; Boscoe M
CMAJ; 2007 Aug; 177(5):484-7. PubMed ID: 17671239
[No Abstract] [Full Text] [Related]
8. The path to eliminate cervical cancer in the world and the challenges of professional education.
Bosch FX
Vaccine; 2012 Nov; 30 Suppl 4():viii-ix. PubMed ID: 23510770
[No Abstract] [Full Text] [Related]
9. The epidemiology behind the HPV vaccine discovery.
Koutsky L
Ann Epidemiol; 2009 Apr; 19(4):239-44. PubMed ID: 19344861
[TBL] [Abstract][Full Text] [Related]
10. Challenges of implementing human papillomavirus (HPV) vaccination policy.
Raffle AE
BMJ; 2007 Aug; 335(7616):375-7. PubMed ID: 17717366
[No Abstract] [Full Text] [Related]
11. Would young women attending sexually transmitted disease clinics benefit from human papillomavirus vaccination? An assessment of human papillomavirus DNA and seropositivity from human papillomavirus sentinel surveillance, 2003-2005.
Dunne EF; Flagg EW; Unger ER; Hsu K; Ghanen K; Kerndt P; Shlay JC; Koutsky LA; Datta DS; Panicker G; Zaidi A; Weinstock H; Markowitz LE
Sex Transm Dis; 2014 Jan; 41(1):46-9. PubMed ID: 24326582
[TBL] [Abstract][Full Text] [Related]
12. Playing games with girls' health: why it is too soon to mandate the HPV vaccine for pre-teen girls as a prerequisite to school entry.
Gendel JE
Seton Hall Law Rev; 2009; 39(1):265-90. PubMed ID: 19288617
[No Abstract] [Full Text] [Related]
13. 'We should welcome the HPV vaccination scheme'.
Warner J
Nurs Times; 2008 Aug 12-18; 104(32):12. PubMed ID: 18777982
[No Abstract] [Full Text] [Related]
14. Human papillomavirus vaccination: expected impacts and unresolved issues.
Dempsey AF; Freed GL
J Pediatr; 2008 Mar; 152(3):305-9. PubMed ID: 18280831
[No Abstract] [Full Text] [Related]
15. Human papillomavirus vaccine: waiting for a miracle.
MacDonald N; Hébert PC
CMAJ; 2007 Aug; 177(5):433, 435. PubMed ID: 17724313
[No Abstract] [Full Text] [Related]
16. Human papillomavirus (HPV) vaccines: a Canadian update.
Foerster V; Murtagh J
Issues Emerg Health Technol; 2007 Dec; (109):1-8. PubMed ID: 18062141
[TBL] [Abstract][Full Text] [Related]
17. Implementation of human papillomavirus immunization in the developing world.
Kane MA; Serrano B; de Sanjosé S; Wittet S
Vaccine; 2012 Nov; 30 Suppl 5():F192-200. PubMed ID: 23199963
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
Novaes HM; de Soárez PC; Silva GA; Ayres A; Itria A; Rama CH; Sartori AM; Clark AD; Resch S
Vaccine; 2015 May; 33 Suppl 1():A135-42. PubMed ID: 25919154
[TBL] [Abstract][Full Text] [Related]
19. Examining mandatory HPV vaccination for all school-aged children.
Skov RE
Food Drug Law J; 2007; 62(4):805-29. PubMed ID: 18557231
[No Abstract] [Full Text] [Related]
20. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
